195 related articles for article (PubMed ID: 35560245)
1. Optical genome mapping for structural variation analysis in hematologic malignancies.
Smith AC; Neveling K; Kanagal-Shamanna R
Am J Hematol; 2022 Jul; 97(7):975-982. PubMed ID: 35560245
[TBL] [Abstract][Full Text] [Related]
2. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
3. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
[TBL] [Abstract][Full Text] [Related]
4. Optical genome mapping enables constitutional chromosomal aberration detection.
Mantere T; Neveling K; Pebrel-Richard C; Benoist M; van der Zande G; Kater-Baats E; Baatout I; van Beek R; Yammine T; Oorsprong M; Hsoumi F; Olde-Weghuis D; Majdali W; Vermeulen S; Pauper M; Lebbar A; Stevens-Kroef M; Sanlaville D; Dupont JM; Smeets D; Hoischen A; Schluth-Bolard C; El Khattabi L
Am J Hum Genet; 2021 Aug; 108(8):1409-1422. PubMed ID: 34237280
[TBL] [Abstract][Full Text] [Related]
5. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
6. Clinical Validation and Diagnostic Utility of Optical Genome Mapping in Prenatal Diagnostic Testing.
Sahajpal NS; Mondal AK; Fee T; Hilton B; Layman L; Hastie AR; Chaubey A; DuPont BR; Kolhe R
J Mol Diagn; 2023 Apr; 25(4):234-246. PubMed ID: 36758723
[TBL] [Abstract][Full Text] [Related]
7. Comparative Benchmarking of Optical Genome Mapping and Chromosomal Microarray Reveals High Technological Concordance in CNV Identification and Additional Structural Variant Refinement.
Barseghyan H; Pang AWC; Clifford B; Serrano MA; Chaubey A; Hastie AR
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895217
[TBL] [Abstract][Full Text] [Related]
8. Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms.
Sahajpal NS; Mondal AK; Tvrdik T; Hauenstein J; Shi H; Deeb KK; Saxe D; Hastie AR; Chaubey A; Savage NM; Kota V; Kolhe R
J Mol Diagn; 2022 Dec; 24(12):1279-1291. PubMed ID: 36265723
[TBL] [Abstract][Full Text] [Related]
9. Detection of cryptic balanced chromosomal rearrangements using high-resolution optical genome mapping.
Zhang S; Pei Z; Lei C; Zhu S; Deng K; Zhou J; Yang J; Lu D; Sun X; Xu C; Xu C
J Med Genet; 2023 Mar; 60(3):274-284. PubMed ID: 35710108
[TBL] [Abstract][Full Text] [Related]
10. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
[TBL] [Abstract][Full Text] [Related]
11. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
[TBL] [Abstract][Full Text] [Related]
12. Optical Genome Mapping as a New Tool to Overcome Conventional Cytogenetics Limitations in Patients with Bone Marrow Failure.
Iriondo J; Gómez A; Zubicaray J; Garcia-Martinez J; Abad L; Matesanz C; Giménez R; Galán A; Sanz A; Sebastián E; González de Pablo J; de la Cruz A; Ramírez M; Sevilla J
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790188
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements.
Andreasson P; Johansson B; Billström R; Garwicz S; Mitelman F; Höglund M
Leukemia; 1998 Mar; 12(3):390-400. PubMed ID: 9529134
[TBL] [Abstract][Full Text] [Related]
14. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
Seegmiller AC; Wasserman A; Kim AS; Kressin MK; Marx ER; Zutter MM; Mosse CA
Leuk Lymphoma; 2014 Mar; 55(3):601-5. PubMed ID: 23876099
[TBL] [Abstract][Full Text] [Related]
15. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
[TBL] [Abstract][Full Text] [Related]
17. [Value of a Panel Fluorescence in Situ Hybridization in Three Kinds of Hematological Malignancies].
Qin YW; Wang XR; Yang YN; Wang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1289-1293. PubMed ID: 27784344
[TBL] [Abstract][Full Text] [Related]
18. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
[TBL] [Abstract][Full Text] [Related]
20. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]